Ralph del Campo
2009
In 2009, Ralph del Campo earned a total compensation of $575.7K as Chief Operating Officer and Principal Executive Officer at Enzon Pharmaceuticals, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $125,000 |
|---|---|
| Salary | $412,885 |
| Other | $37,828 |
| Total | $575,714 |
del Campo received $412.9K in salary, accounting for 72% of the total pay in 2009.
del Campo also received $125K in non-equity incentive plan and $37.8K in other compensation.
Rankings
In 2009, Ralph del Campo's compensation ranked 6,360th out of 9,885 executives tracked by ExecPay. In other words, del Campo earned more than 35.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,360 out of 9,885 | 36th |
Division Manufacturing | 2,320 out of 3,690 | 37th |
Major group Chemicals And Allied Products | 503 out of 866 | 42nd |
Industry group Drugs | 339 out of 638 | 47th |
Industry Biological Products, Except Diagnostic Substances | 68 out of 133 | 49th |
Source: SEC filing on April 8, 2011.
del Campo's colleagues
We found five more compensation records of executives who worked with Ralph del Campo at Enzon Pharmaceuticals in 2009.
2009
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2009
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2009
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2009
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2009
Mark Ogden
Enzon Pharmaceuticals